Surrogacy Market - By Type (Gestational Surrogacy, Traditional Surrogacy), By Technology (Intrauterine Insemination (IUI), In-vitro Fertilization (IVF)), By Age Group, By Service Provider & Forecast, 2023-2032

Surrogacy Market Size

Surrogacy Market size was valued at more than USD 14 billion in 2022 and is anticipated to depict over 24.5% CAGR from 2023 to 2032.
 

Growing prevalence of obesity coupled with unhealthy habits such as smoking has increased the number of patients diagnosed with infertility. Sedentary lifestyles and a lack of physical exercise have severely affected the reproductive ability of men and women.
 

As per the American Pregnancy Association, 30% of the male population suffers from infertility, accounting for one-fifth of the total infertility cases. Furthermore, estimates from the Centers for Disease Control and Prevention (CDC) state that close to 12.1% of women between 15 to 44 years are unable to conceive. These factors are the result of hormonal imbalances and the subsequent reduction in the production of sperm, thereby promoting the use of alternatives such as surrogacy.
 

Ethical concerns associated with surrogacy, however, have led some countries to ban the procedure. Limitations regarding stringent regulations for commercial surrogacy in developed nations like the United States may restrict market growth to a certain extent. Different countries have different surrogacy laws and there are no concrete regulations for this matter. Furthermore, fertility clinics work under separate guidelines and medical laws. These non-uniform and stringent regulations may hamper the surrogacy industry progress.
 

Surrogacy Market Analysis

Surrogacy market from the Intrauterine insemination (IUI) technology is anticipated to register a 24% CAGR between 2023 to 2032. IUI, or donor insemination, is a process where healthy sperm is placed into the uterus to get closer to the egg, increasing the chances of fertilization. This technology is gaining traction among women in their early 30s, given its success rate of between 20-25%. Additionally, the IUI procedure is minimally invasive and cost-effective in comparison to other surrogacy treatments. Considering these advantages demonstrated by the technology, the adoption of IUI for surrogacy procedures is likely to increase over the forthcoming years.
 

Surrogacy market from the 40-42 years age group is projected to be worth over USD 13.5 billion by 2032. Rising number of working women between 40 to 42 years of age has led to increased stress levels, asserting a significant impact on reproduction ability. Working women are also becoming increasingly aware of procedures such as in-vitro fertilization (IVF), which enables them to conceive a pregnancy. Since women over 40 generally face irregular menstrual cycles which reduces their chances of conceiving naturally, the adoption of surrogacy procedures is expected to increase among this age group.
 

Surrogacy market from the hospitals service provider segment is expected to record over 24% CAGR from 2023 to 2032. This can be attributed to the growing infrastructural development of healthcare organizations. The increased integration of advanced surrogacy technologies such as Intrauterine insemination (IUI) is also shifting the preference of patients toward hospitals. Moreover, hospitals often employ surrogacy specialists that offer effective fertility treatment at a higher success rate, further encouraging patients to opt for surrogacy procedures in hospital settings.
 

Europe surrogacy market is projected to be valued at USD 61 billion by 2032. Improved healthcare infrastructure has increased the adoption of novel technology-based surrogacy procedures in the region. The European Union (EU) has also implemented various health policies, such as the EU4Health program which was adopted in March 2021 and valued at USD 5.12 billion (€5.1 billion), to promote investment and innovation in healthcare. The growing acceptance of the procedure, in addition to favorable regulatory policies, will fuel regional surrogacy industry forecasts.
 

Surrogacy Market Share

Some of the major companies operating in the surrogacy market include :

• IVIRMA
• Boston IVF
• Ovation Fertility
• Extraordinary Conceptions
• Circle Surrogacy
• Growing Generations
• New Hope Fertility Clinic
• Bourn Hall International (TVM Capital Healthcare)

Many of these companies are focusing on strategic collaborations to expand their business footprint and strengthen their market position.
 

Citing an instance in January 2022, Boston IVF partnered with Delaware Institute for Reproductive Medicine (DIRM). This collaboration was intended to help the firm deliver state-of-the-art fertility treatments through advanced procedures such as In-vitro Fertilization (IVF), male infertility, preimplantation genetic testing, and egg freezing among others.
 

Impact of COVID-19 Pandemic

The COVID-19 pandemic affected millions of people across the world which resulted in higher mortality rates. The high risk of infection during surgeries, alongside lockdown restrictions implemented in the early stages of the crisis, impacted the demand for elective procedures such as surrogacy.
 

For instance, in September 2020, the American Society of Reproductive Medicine and the Canadian Fertility and Andrology Society announced plans to immediately suspend all fertility treatments in Canada and the United States owing to the COVID-19 disease outbreak. However, with global conditions gradually stabilizing in late 2021, clinics and hospitals resumed their operations with stringent guidelines and precautions. This may, in turn, facilitate the recovery of the market post-pandemic.
 

Global surrogacy market research report includes in-depth coverage of the industry with estimates & forecasts in terms of volume in Kilo Tons and revenue in USD Billion from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Type

• Gestational Surrogacy
• Traditional Surrogacy

By Technology

• Intrauterine insemination (IUI)
• In-vitro fertilization (IVF)
  • Classical/standard IVF
  • Intracytoplasmic sperm injection (ICSI)
• Others

By Age Group

• Below 35 Years
• 35-37 Years
• 38-39 Years
• 40-42 Years
• 43-44 Years
• Over 44 Years

By Service Provider

• Hospitals
• Fertility Clinics
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Others
• Europe
  • Czech Republic
  • Estonia
  • Georgia
  • Greece
  • Poland
  • Sweden
  • UK
  • Others
• Asia Pacific
  • India
  • Thailand
  • South Korea
  • Others
• Africa
  • Kenya
  • Nigeria
  • South Africa
  • Others